公司概覽
業務類別 Diagnostics & Research
業務概覽 Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
公司地址 3100 Hanover Street, Palo Alto, CA, USA, 94304
電話號碼 +1 855 698-8887
傳真號碼 +1 888 974-4258
公司網頁 https://www.guardanthealth.com
員工數量 2506
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Darya Chudova Chief Technology Officer 美元 520.19K 28/04/2026
Ms. Terilyn Juarez Monroe Chief People Officer -- 28/04/2026
Mr. John G. Saia Chief Legal Officer and Corporate Secretary 美元 527.12K 28/04/2026
Mr. Michael Brian Bell Chief Financial Officer and Principal Accounting Officer 美元 566.15K 28/04/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board 美元 1 28/04/2026
Mr. Kumud Kalia Chief Information Officer -- 28/04/2026
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director 美元 1 28/04/2026
Mr. Christopher Freeman Chief Commercial Officer -- 28/04/2026
Dr. Craig Eagle, M.D. Chief Medical Officer 美元 576.15K 27/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Ian T. Clark Lead Independent Director 28/04/2026
Mr. Musa Tariq Independent Director 28/04/2026
Ms. Myrtle S. Potter Independent Director 28/04/2026
Ms. Vijaya Gadde Independent Director 28/04/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 28/04/2026
Mr. Alex M. Azar,II Independent Director 28/04/2026
Mr. Roberto A. Mignone Independent Director 28/04/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board 28/04/2026
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director 28/04/2026
Ms. Meghan V. Joyce Independent Director 28/04/2026
Mr. Steven E. Krognes, M.B.A. Independent Director 28/04/2026
 
所屬ETF (更新日期: 02/05/2026 02:17)
代號 名稱 佔比% 持有日期
NUSCNuveen ESG Small-Cap ETF0.02%29/04/2026
FNXFirst Trust Mid Cap Core AlphaDEX® ETF0.02%29/04/2026
FTQIFirst Trust Nasdaq BuyWrite Income ETF0.02%27/04/2026
GNOMGlobal X Genomics & Biotechnology ETF0.02%29/04/2026
JSMLJanus Henderson Small Cap Gr Alpha ETF0.02%29/04/2026
ESGVVanguard ESG US Stock ETF0.02%31/03/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.02%29/04/2026
XTiShares Future Exponential Techs ETF0.02%28/04/2026
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF0.02%29/04/2026
PINKSimplify Health Care ETF0.02%29/04/2026
XHSStt Strt® SPDR® S&P®HlthCrSvcsETF0.02%29/04/2026
BKMCBNY Mellon US Mid Cap Core Equity ETF0.02%29/04/2026
FSMLFranklin Small Cap Enhanced ETF0.01%29/04/2026
SEISSEI Select Small Cap ETF0.01%29/04/2026
IQSMNYLI Candriam U.S. Mid Cap Equity ETF0.01%29/04/2026
HELXFranklin Genomic Advancements ETF0.01%29/04/2026
CANCTema Oncology ETF0.01%29/04/2026
AAUAAlpha Architect US Equity 3 ETF0.01%10/04/2026
HTECRobo Global® Hlthcare Tech & Innovt ETF0.01%29/04/2026
GSGOGoldman Sachs Growth Opportunities ETF0.01%29/04/2026
  1    2   3    4    5    6    7    8    9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.